NC Medial Research Inc
This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.
Ischemic Stroke
NCS-01
PHASE1
PHASE2
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 16 participants |
Masking : | QUADRUPLE |
Primary Purpose : | TREATMENT |
Official Title : | A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke |
Actual Study Start Date : | 2020-02-27 |
Estimated Primary Completion Date : | 2027-10 |
Estimated Study Completion Date : | 2028-10 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 85 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
University of Miami
Miami, Florida, United States, 33136